Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

Radiation therapy is a treatment that uses high doses of radiation to damage cancer cells, either killing them or slowing their growth. Unlike the low-dose radiation used in X-rays to see inside the ...

Doctors at Boston’s Beth Israel share how CAR T cell therapy and other emerging immune therapies are delivering promising ...

Around 2600 people with untreated multiple myeloma and over 23,000 people with ulcerative colitis in England are set to benefit from new treatment options following final draft guidance from the ...

Eight presentations at ASCO and EHA 2023 Annual Meetings showcase continued leadership in CAR-T cell therapy research for patients with multiple myeloma across various clinical settings First analysis ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The good news, I guess, is that we have ...

New research has found that venetoclax, a medication currently approved for leukemia, has benefits for patients with multiple myeloma when used in combination with another drug. This discovery offers ...

Experts discuss challenges in induction regimens for transplant-ineligible myeloma patients, and evolving approaches, quad regimens, dynamic frailty, and upcoming trials shaping future treatment ...

Multiple myeloma is a cancer of plasma cells in the bone marrow. While it is still considered incurable, treatments have improved significantly in recent years, helping patients live longer and feel ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Common manifestations and complications of multiple myeloma (MM) can include bone complications, hypercalcemia, renal insufficiency, infection, skeletal lesions and anemia. Other less common ...

A myeloma survivor in long remission shares how research, expert care and advocacy turned fear into hope as more patients ...